Abstract
Pulmonary vein isolations is the conventional rhythm-control therapy in treatment-resistant Atrial Fibrillation (AF). Cryoablation has emerged as a successful therapeutic option as it confers a beneficial effect on procedure time without compromising safety and efficacy due to its single-shot circumferential approach without conduction gap [1], in contrast to the conventional point-by-point application of radiofrequency energy [2]. This audit aimed to determine the clinical effectiveness of novel 28 mm cryoballoon ablation in Pulmonary Vein Isolations (PVIs) measured by freedom from AF from patients perspectives.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
